a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSIIX | 53.03 | N/A | N/A |
Goldman Sachs Equity Income Instl | |||
RWMHX | 65.33 | -0.43 | -0.65% |
American Funds Washington Mutual R5E | |||
WFDAX | 29.72 | -0.25 | -0.83% |
Allspring SMID Cap Growth Fund - Cl A | |||
LMVVX | 33.24 | -0.34 | -1.01% |
Lord Abbett Focused Small Cap Value R5 | |||
QUAZX | 78.77 | -1.67 | -2.08% |
AB Small Cap Growth Z |
A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ZYME. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ZYME could also see price increases.
Ticker / NAME | Correlation To APLS | 1D Price Change % | ||
---|---|---|---|---|
APLS | 100% | -1.08% | ||
ZYME - APLS | 39% Loosely correlated | +0.40% | ||
PGEN - APLS | 38% Loosely correlated | -5.86% | ||
INZY - APLS | 37% Loosely correlated | -6.00% | ||
IMVT - APLS | 36% Loosely correlated | -6.01% | ||
BCRX - APLS | 36% Loosely correlated | -4.52% | ||
More |